Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-κB Ligand (RANKL)-induced JNK Activation
Open Access
- 1 March 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (12), 8836-8840
- https://doi.org/10.1074/jbc.m010764200
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisNature, 1999
- Mice Lacking the Type I Interleukin-1 Receptor Do Not Lose Bone Mass after OvariectomyEndocrinology, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLProceedings of the National Academy of Sciences, 1998
- Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosisJournal of Bone and Mineral Research, 1996
- Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of OsteoporosisNew England Journal of Medicine, 1995
- Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.Journal of Clinical Investigation, 1993
- MACROPHAGE COLONY STIMULATING FACTOR RESTORESIN VIVOBONE RESORPTION IN THEOP/OPOSTEOPETROTIC MOUSEEndocrinology, 1990
- The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor geneNature, 1990
- Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow culturesJournal of Bone and Mineral Research, 1986